secwatch / observer
8-K filed January 17, 2023, 6:59 PM ET ticker VYNE CIK 0001566044
other material confidence high sentiment neutral materiality 0.25

VYNE redeems all Series A Preferred Stock for $360K, eliminates series designation

VYNE Therapeutics Inc.

item 5.03item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

VYNE Therapeutics Inc.: Filed a Certificate of Elimination to remove the designation of Series A Convertible Preferred Stock from the Amended and Restated Certificate of Incorporation, making those shares authorized but unissued preferred stock (effective 2023-01-17).

Change
charter amendment
Effective
2023-01-17
Exact text from the filing
On January 17, 2023, the Company filed a Certificate of Elimination (the “Certificate”) with the Secretary of State of the State of Delaware with respect to the Series A Preferred Stock. The Certificate (i) eliminated the previous designation of 3,000 shares of Series A Preferred Stock from the Company’s Amended and Restated Certificate of Incorporation, none of which were outstanding at the time of filing, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock.
View on SEC.gov

Browse all governance changes →

VYNE Therapeutics Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-004316
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.